Cantor Fitzgerald is maintaining a bearish stance on equities, cautioning that the recent market rebound which has been driven largely by investor positioning—is likely behind us. The firm ...

On Tuesday, Cantor Fitzgerald analyst Sarah James reaffirmed an Overweight rating on CVS Health (NYSE:CVS) with a steady price target of $71.00. The rating aligns with the company’s strong ...

Fintel reports that on May 5, 2025, Cantor Fitzgerald downgraded their outlook for Onto Innovation (BMV:ONTO) from Overweight to Neutral. There are 501 funds or institutions reporting positions in ...

On Monday, Cantor Fitzgerald analysts revised their stance on Onto Innovation Inc. (NYSE:ONTO), downgrading the stock from Overweight to Neutral and significantly reducing the price target to $135 ...

Cantor Fitzgerald High Income Fd earns an Above Average Process Pillar rating. The largest contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 71%. The measure ...

On Monday, Cantor Fitzgerald analysts revised their stance on Onto Innovation Inc. (NYSE:ONTO), downgrading the stock from Overweight to Neutral and significantly reducing the price target to $135 ...

On Tuesday, Cantor Fitzgerald analyst Sarah James reaffirmed an Overweight rating on CVS Health (NYSE:CVS) with a steady price target of $71.00. The rating aligns with the company’s strong market ...

Cantor Fitzgerald & Co. acted as the sole book-running manager for the offering. About Cantor Equity Partners II, Inc. Cantor Equity Partners II, Inc. is a blank check company sponsored by Cantor ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The most important driver of the rating is the parent firm's five-year risk-adjusted success ratio of 71%.